FDA approves durvalumab for adults with limited-stage small cell #LungCancer (LS-SCLC) who have not progressed after concurrent platinum-based chemotherapy and radiation. Efficacy was demonstrated in the ADRIATIC trial

https://buff.ly/3OCSXfz

@stephenvliu.bsky.social
@biagioricciutimd.bsky.social

Dear Colleagues
A Pleasure to introduce some our #OncoAlertAF

Associate Faculty 🚨
@elisaagostinetto.bsky.social 🇧🇪
@elisabettabonzano.bsky.social 🇮🇹
@realbowtiedoc.bsky.social 🇺🇸
@biagioricciutimd.bsky.social 🇺🇸
@weoncologists.bsky.social 🇺🇸
@drnataliagandur.bsky.social 🇦🇷